106 related articles for article (PubMed ID: 22064117)
1. Multistage high-dose I-131 treatment for a nonthyroidectomized patient with metastatic differentiated thyroid cancer.
Ahn BC; Lee SW; Lee J
Clin Nucl Med; 2011 Dec; 36(12):e224-7. PubMed ID: 22064117
[No Abstract] [Full Text] [Related]
2. Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer.
Campennì A; Violi MA; Ruggeri RM; Sindoni A; Moleti M; Vermiglio F; Baldari S
Nucl Med Commun; 2010 Apr; 31(4):274-9. PubMed ID: 20087239
[TBL] [Abstract][Full Text] [Related]
3. [Multimodal therapy concept in advanced distant metastasis of a follicular thyroid carcinoma].
Römer W; Florack G; Schwaiger M; Langhammer HR
Nuklearmedizin; 2002 Jun; 41(3):N27-9. PubMed ID: 12109039
[No Abstract] [Full Text] [Related]
4. Comparison of efficacy of 2220 MBq versus 3700 MBq I-131 for ablation of thyroid remnant in patients with differentiated thyroid cancer.
Fish SA; Basu S; Alavi A; Mandel SJ
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):560-3. PubMed ID: 20927023
[TBL] [Abstract][Full Text] [Related]
5. Use of 131 I-MIBG therapy in MIBG-positive metastatic medullary thyroid carcinoma.
Maiza JC; Grunenwald S; Otal P; Vezzosi D; Bennet A; Caron P
Thyroid; 2012 Jun; 22(6):654-5. PubMed ID: 22568397
[No Abstract] [Full Text] [Related]
6. Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
Akkas BE; Demirel BB; Vural GU
Thyroid; 2014 Feb; 24(2):287-95. PubMed ID: 23750862
[TBL] [Abstract][Full Text] [Related]
7. Thyrotoxicosis due to functioning metastatic follicular thyroid carcinoma after twelve I-131 therapies.
Tan J; Zhang G; Xu W; Meng Z; Dong F; Zhang F; Jia Q; Liu X
Clin Nucl Med; 2009 Sep; 34(9):615-9. PubMed ID: 19692828
[TBL] [Abstract][Full Text] [Related]
8. [Importance of scintigraphy in the evaluation of surgical treatment outcome in differentiated cancer of the thyroid gland].
Protsyk VS; Shishkina VV; Chebotareva ED; Siniuta BF; Dzhuzha DA; Sagan DL
Klin Khir; 1997; (9-10):29-32. PubMed ID: 9511322
[TBL] [Abstract][Full Text] [Related]
9. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of malignant thyroid neoplasms].
Reichmann J; Gläser A; Löbe J
Zentralbl Chir; 1969 Sep; 94(38):1241-51. PubMed ID: 4984513
[No Abstract] [Full Text] [Related]
11. An aggressive radio-resistant papillary thyroid cancer.
Mehta RS; Negin B; Popii V; Langer C
Clin Adv Hematol Oncol; 2008 Oct; 6(10):761-7. PubMed ID: 18997667
[No Abstract] [Full Text] [Related]
12. Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases.
Higashi T; Nishii R; Yamada S; Nakamoto Y; Ishizu K; Kawase S; Togashi K; Itasaka S; Hiraoka M; Misaki T; Konishi J
J Nucl Med; 2011 May; 52(5):683-9. PubMed ID: 21498534
[TBL] [Abstract][Full Text] [Related]
13. Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer?
Bal CS; Kumar A; Chandra P; Dwivedi SN; Mukhopadhyaya S
Thyroid; 2004 Mar; 14(3):217-25. PubMed ID: 15072704
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphic TNM staging of tumors: a proposition.
Oommen R
J Nucl Med; 2009 Aug; 50(8):1386; author reply 1386. PubMed ID: 19617337
[No Abstract] [Full Text] [Related]
15. Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients.
Castagna MG; Cevenini G; Theodoropoulou A; Maino F; Memmo S; Claudia C; Belardini V; Brianzoni E; Pacini F
Eur J Endocrinol; 2013 Jul; 169(1):23-9. PubMed ID: 23594687
[TBL] [Abstract][Full Text] [Related]
16. Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients.
Mishra A; Pradhan PK; Gambhir S; Sabaretnam M; Gupta A; Babu S
J Surg Res; 2015 Feb; 193(2):731-7. PubMed ID: 25193578
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients.
Lee JW; Lee SM; Lee DH; Kim YJ
J Nucl Med; 2013 Aug; 54(8):1230-6. PubMed ID: 23813775
[TBL] [Abstract][Full Text] [Related]
18. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
19. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer.
Maxon HR; Thomas SR; Hertzberg VS; Kereiakes JG; Chen IW; Sperling MI; Saenger EL
N Engl J Med; 1983 Oct; 309(16):937-41. PubMed ID: 6621620
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous metastasis from follicular carcinoma of the thyroid gland.
Caron P; Moreau-Cabarrot A; Gorguet B; Bazex J
Thyroid; 1993; 3(3):235-7. PubMed ID: 8257865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
